癌症中的AKR1C3:从多方面的作用到治疗策略
Mengnan Li1, Limin Zhang2,3, Jiahui Yu1
1School of Basic Medicine, Health Science Center, Yangtze University, Jingzhou, China.
Frontiers in pharmacology
|March 25, 2024
概括
艾尔多基托降解酶家族1成员C3 (AKR1C3) 通过促进雄激素信号传递,驱动癌症生长和治疗耐药性. 抑制AKR1C3显示出抑制瘤进展和克服癌症治疗中抗性的承诺.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 阿尔多基因缩酶家族1成员C3 (AKR1C3),也称为17β-HSD5,对安德روج因生物合成至关重要.
- 升高的AKR1C3水平激活了雄激素受体信号,促进了瘤的进展和治疗耐药性.
- 过度表达AKR1C3与癌症患者的预后和生存率不佳有关.
研究的目的:
- 综合审查AKR1C3在癌症发展中的作用.
- 分析AKR1C3对治疗耐药性的影响.
- 为突出 AKR1C3 抑制剂在癌症治疗中的最新进展.
主要方法:
- 对AKR1C3功能,过度表达和抑制研究的文献综述.
- 分析AKR1C3的酶活性及其对类固醇激素代谢的影响.
- 对AKR1C3抑制剂的临床前和临床数据的检查.
主要成果:
- AKR1C3催化了雄激素和雌激素的转化,影响了依赖激素的癌症.
- 过度表达AKR1C3促进癌细胞的增殖,入侵和转移.
- 抑制AKR1C3在抑制瘤生长和克服抵抗方面表现出显著的有效性.
结论:
- AKR1C3是关键的致癌因子,也是癌症治疗的有前途的治疗标.
- 包括天然产品在内的新型AKR1C3抑制剂的开发正在迅速推进.
- 针对AKR1C3提供了一种改善癌症治疗结果的潜在策略.
更多相关视频
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
1.8K
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
749
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
